Home › NDC Lookup › Ingredients › Clotrimazole › 29978-0918-60
Alevazol Clotrimazole 10 mg/g Ointment, 1 tube — NDC 29978-0918-60 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Alevazol Clotrimazole 10 mg/g Ointment, 1 tube — NDC 29978-918-60 (Billing 29978-0918-60)

by Capital Pharmaceutical, LLC · 1 TUBE in 1 CARTON / 56.7 g in 1 TUBE

This is a package of 1 tube of Alevazol Clotrimazole 10 mg/g Ointment from Capital Pharmaceutical, LLC, marketed since Sep 2014 and currently FDA-listed. It is this product's only package size.

NDC 29978-0918-60
🏷️ FDA NDC (as labeled) 29978-918-60 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 29978-918-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
29978 labeler · 918 product · 60 package
Package marketed since
Sep 1, 2014
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 2997891860 6
Medicaid fills, this package
2,383 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Clotrimazole (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0210-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0211-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 29978-918-60
Product NDC 29978-918
11-digit billing NDC 29978091860
NCPDP billing unit GM — per gram (weight)
RxCUI 418475, 1543313
UNII G07GZ97H65
SPL Set ID edd8da89-0b83-4de6-a166-7451d0084169
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-09-01
Route TOPICAL
Dosage form OINTMENT
Substance CLOTRIMAZOLE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90154020004230
GPI class Alevazol
GCN Seq No 028800
GCN 00685
HICL code 004137
Ingredient (HICL) Clotrimazole
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.08
AHFS class Azoles (Skin And Mucous Membrane)
FDB label name ALEVAZOL 1% OINTMENT
FDB brand name Alevazol
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 028800
  • GCN: 00685
  • GPI-14 (Medi-Span): 90154020004230
  • HICL (First Databank): 004137
  • AHFS class code: 84:04.08.08
  • RxCUI (RxNorm): 418475
Why two NDCs? The FDA registers this code as 29978-918-60 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 29978-0918-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole and triazole derivatives, Imidazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ALEVAZOL 1% OINTMENT Ingredient Clotrimazole
📖 What it is MedlinePlus · NLM

Topical clotrimazole is used to treat tinea corporis (ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Clotrimazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats fungal and yeast infections. Skin products treat athlete's foot, jock itch and ringworm. Vaginal creams treat vaginal yeast infections, and CLOTIC ear solution treats fun...
  • Wash and dry the area, then apply a thin layer twice a day, morning and night. Most labels say about 4 weeks for athlete's foot and ringworm and 2 weeks for jock itch. See a doctor...
  • The skin products listed here say they are not effective on the scalp or nails. If the infection is there, check with your doctor.
  • With CLOTIC ear solution, the reported ones were headache, pain where it goes in, ringing in the ear and tingling. Vaginal cream can briefly increase burning or itching. Call your...
📖 Read our full Clotrimazole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo $0.3444 $19.53 / 56.7 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
29978-0918-60 You're viewing this Main listing 1 TUBE in 1 CARTON / 56.7 g in 1 TUBE 2014-09-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Clotrimazole 1% Athletes Foot 10 mg/g 70677-1002-01 STRATEGIC 1 tube $0.118 — Availability likely —
Good Neighbor Pharmacy Clotrimazole 10 mg/g 24385-0205-01 AmerisourceBergen 1 tube $0.197 — Availability likely —
Clotrimazole 10 mg/g 68462-0181-17 Glenmark 15 g $0.199 AB Availability likely —
Clotrimazole 10 mg/g 51672-1275-01 Sun 1 tube $0.199 AB Availability likely —
Terrasil Ringworm Treatment MAX 1 g/100g 24909-0102-14 Aidance 14 g — — Discontinued —
Terrasil Tinea Treatment MAX 1 g/100g 24909-0104-14 Aidance 14 g — — Discontinued —
Terrasil Anti-Fungal Treatment MAX 1 g/100g 24909-0106-14 Aidance 14 g — — Discontinued —
Terrasil Athletes Foot AntiFungal Treatment Max 1 g/100g 24909-0207-25 Aidance 25 g — — Discontinued —
Terrasil JockItch Treatment Maximum Strength 1 g/100g 24909-0212-50 Aidance 50 g — — FDA listed —
Terrasil Jock Itch Treatment Maximum Strength 1 g/100g 24909-0214-14 Aidance 14 g — — FDA listed —
Alevazol 10 mg/gthis 29978-0918-60 Capital 1 tube — — FDA listed —
Hua Tuo Xian Gao Antifungal 1 g/100g 55614-0650-01 MADISON 1 tube — — FDA listed —
Hermon Antifungal Stick .4 g/40g 85398-0021-01 Beautivity 40 g — — FDA listed —
Jock-Eze 10 mg/g 47832-0071-14 Bentlin 1 tube — — FDA listed —
Clotrimazole 10 mg/g 71205-0432-15 Proficient 1 tube — AB FDA listed —
Thera plus Antifungal Clotrimazole 10 mg/g 80684-0039-01 FOURSTAR 1 tube — — FDA listed —
Lotrimin 10 mg/g 11523-6549-01 Bayer 1 tube — — FDA listed —
Clotrimazole Athletes Foot 10 mg/g 49035-0812-01 Wal-Mart 1 tube — — FDA listed —
Clotrimazole 10 mg/g 50090-7343-00 A-S 30 g — AB FDA listed —
Micomitin Antifungal 10 mg/g 59088-0642-07 PureTek 85 g — — FDA listed —
CVS Pharmacy ITCH RELIEF ANTIFUNGAL 10 mg/g 59779-0510-01 CVS 1 tube — — FDA listed —
Lotrimin Antifungal 10 mg/g 11523-1125-01 Bayer 1 tube — — FDA listed —
Clotrimazole 1% Athletes Foot 10 mg/g 69771-0032-23 GERI-GENTLE 113 g — — FDA listed —
Signature Care Athletes Foot 10 mg/g 21130-0870-14 Safeway 1 tube — — FDA listed —
HEB Antifungal 10 mg/g 37808-0305-01 H 1 tube — — FDA listed —
Clotrimazole 1% Athletes Foot 10 mg/g 52410-3024-04 Shield 28.3 g — — FDA listed —
Fortinia 10 mg/g 54633-0314-80 The 80 g — — FDA listed —
Clotrimazole 1% Athletes Foot 10 mg/g 59779-0305-01 CVS 1 tube — — FDA listed —
Clotrimazole Jock Itch 10 mg/g 11822-3423-01 Rite 1 tube — — FDA listed —
CAREONE Clotrimazole 10 mg/g 41520-0305-02 American 1 tube — — FDA listed —
Clotrimazole 10 mg/g 00168-0133-15 E. 15 g — AB Discontinued —
Major Clotrimazole 10 mg/g 66267-0980-15 NuCare 14.17 g — — FDA listed —
Walgreens Jock Itch 10 mg/g 00363-2109-01 Walgreen 1 tube — — FDA listed —
Clotrimazole 10 mg/g 84387-0004-01 ALLIED 28.4 g — — FDA listed —
Clotrimazole 1% 10 mg/g 87228-1010-01 PHARMACY 28.4 g — — FDA listed —
Lotrimin 10 mg/g 11523-0963-01 Bayer 1 tube — — FDA listed —
Jock Itch 10 mg/g 11673-0062-15 TARGET 1 tube — — FDA listed —
Antifungal 10 mg/g 21922-0094-04 Encube 1 tube — — FDA listed —
Kroger ATHLETES FOOT 10 mg/g 30142-0305-01 Kroger 1 tube — — FDA listed —
CAREALL Clotrimazole 10 mg/g 51824-0093-01 New 28 g — — FDA listed —
Fungicure Liquid Gel 10 mg/g 52389-0733-09 Kobayashi 1 tube — — FDA listed —
Micotrin AC 10 mg/g 59088-0476-07 PureTek 85 g — — FDA listed —
WinCo Foods Antifungal 10 mg/g 67091-0196-28 Winco 1 tube — — FDA listed —
Ringworm 10 mg/g 00363-2107-01 Walgreen 1 tube — — FDA listed —
Signature Care Jock Itch 10 mg/g 21130-0210-01 Safeway 1 tube — — FDA listed —
Fungicure Night Cream 10 mg/g 52389-0681-02 Kobayashi 1 tube — — FDA listed —
Family Wellness Clotrimazole 1 Anti Fungal Cream 10 mg/g 55319-0980-00 Family 1 tube — — FDA listed —
Megababe Fun Gal Stuff Antifungal 10 mg/g 84000-0908-00 Megababe 1 tube — — FDA listed —
Family Care Antifungal 10 mg/g 65923-0052-28 United 1 tube — — FDA listed —
Clotrimazole 10 mg/g 67296-2252-03 Redpharm 30 g — AB FDA listed —
Clotrimazole 10 mg/g 00363-2105-01 Walgreen 1 tube — — FDA listed —
Tinea Versicolor Treatment Cream 10 mg/g 85398-0002-01 Beautivity 60 g — — FDA listed —
TopCare Antifungal 10 mg/g 36800-0495-69 Topco 1 tube — — FDA listed —
Tagrid Antifungal Treament Clotrimazole 1% 10 mg/g 85384-0012-01 TAGRID 20 g — — FDA listed —
FifthPulse Clotrimazole Antifungal 10 mg/g 87525-0002-01 WeCare 1 tube — — FDA listed —
Publix athletic foot 10 mg/g 41415-0056-75 Publix 1 tube — — FDA listed —
Live Better Antifungal 10 mg/g 51143-0002-01 The 1 tube — — FDA listed —
DG Health Athletes Foot 10 mg/g 55910-0118-00 Dolgencorp, 57 g — — FDA listed —
Mycozyl AC 10 mg/g 59088-0441-07 PureTek 85 g — — FDA listed —
Tinea Versicolor Treatment Bar 10 mg/g 85398-0003-01 Beautivity 116 g — — FDA listed —
Dr Sheffield Athletes Foot 10 mg/g 11527-0071-15 Sheffield 1 tube — — Discontinued —
UpandUp Clotrimazole 10 mg/g 11673-0910-02 Target 1 tube — — FDA listed —
Kroger Jock Itch 10 mg/g 30142-0510-01 Kroger 1 tube — — FDA listed —
meijer Athletes Foot 10 mg/g 41250-0305-02 Meijer 1 tube — — FDA listed —
Athletes Foot 10 mg/g 55315-0008-56 FRED'S, 1 tube — — FDA listed —
Clotrimazole 1% 10 mg/g 68747-3024-04 Dabur 28.3 g — — FDA listed —
CAREALL Clotrimazole 10 mg/g 51824-0121-01 New 28 g — — FDA listed —
Clotrimazole 10 mg/g 73581-0451-01 YYBA 1 tube — — FDA listed —
Shailee Antifungal Cream 10 mg/g 87995-0001-01 Skinley 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
Sep 2014
📍
2026
Currently FDA-listed
12 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Clotrimazole inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII KIZ4X2EHYX
    A plant extract from the aloe vera leaf, used in medicines as a moisturizing agent and skin-conditioning ingredient. It helps soften and soothe the product's texture in topical formulations.
  • UNII 5QB0T2IUN0
    Aluminum hydroxide is a white powder mineral compound used as an antacid ingredient in some formulations. It works as a buffer and pH regulator to help neutralize stomach acid in the medicine.
  • UNII Q1LS2UJO3A
    Ceresin is a purified mineral wax derived from ozocerite. It functions as a binding agent, thickener, and coating material in medicines to help hold ingredients together and provide texture or protective coating.
  • UNII 7EV65EAW6H
    Lanolin is a waxy substance derived from sheep's wool. It's used in medicines as an emollient and skin-conditioning agent to soften formulations and improve spreadability in topical products like creams and ointments.
  • UNII T5L8T28FGP
    Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAloe Vera Gel, Ceresin Wax, Dried Aluminum Hydroxide Gel USP (for Coloring), Lanolin USP, Mineral Oil USP, Snow White PET-G USP.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCapital Pharmaceutical, LLC
Labeler code29978
First marketedSep 2014
Product typeHuman Otc Drug
Portfolio6 products on file

More NDCs from Capital Pharmaceutical, LLC labeler code 29978

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 33 words ▾

Uses Clears up most tinea cruris, candida albicans or tinea corporis. For effective relief of itching, scaling, cracking, burning, redness, soreness & irritation. For discomfort, scaly skin between the toes or burning feet.

⏱️ Dosage and Administration 114 words ▾

Directions. Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor.

Supervise children in the use of this product. For athlete’s foot and ringworm: use daily for 4 weeks. For Candida Albicans use daily for 2 weeks.

For athletes foot: Pay special attention to spaces between toes; wear well fitting, ventilated shoes and change shoes and socks at least one daily. If condition persists longer, consult a doctor. This product is not effective on the scalp or nails Other Information.

Store at 15deg –30deg C (59deg-86deg F) Lot No and Exp Date: See Crimp of tube.

⚠️ Warnings 5 words ▾

Warning. For external use only.

🧪 Active Ingredient 3 words ▾

Active Ingredient Clotrimazole

🧪 Inactive Ingredients 23 words ▾

Inactive Ingredients. Aloe Vera Gel, Ceresin Wax, Dried Aluminum Hydroxide Gel USP (for Coloring), Lanolin USP, Mineral Oil USP, Snow White PET-G USP.

🎯 Purpose 2 words ▾

Purpose Antifungal

📄 When Using This Product 8 words ▾

When Using This Product Avoid contact with eyes.

📄 Stop Use and Ask a Doctor If 29 words ▾

Stop Use and Ask a Doctor if . Irritation occurs There is no improvement within 4 weeks (for athletes foot and ringworm) or within 2 weeks (for jock itch)

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 5 words ▾

Question? Comments? Call 1-(614) 638-4622

📄 Package Label / Principal Display Panel 22 words ▾

PRINCIPAL DISPLAY PANEL Alevazol with ACTIVE aloe ® CLOTRIMAZOLE 1% OINTMENT ANTIFUNGAL PRINCIPAL DISPLAY PANEL Alevazol with ACTIVEaloe® CLOTRIMAZOLE 1% OINTMENT ANTIFUNGAL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
2.4K
Units reimbursed last 4 qtrs
145K
Gross reimbursed last 4 qtrs
$49.9K
Avg / prescription
$20.95
Avg / unit
$0.3444
Latest quarter Q4 2025
649Rx
Fee-for-service vs managed care ⓘ
24% FFS 76% MCO
Fee-for-service · 564 Rx Managed care · 1,819 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: 11,113 units · 188 per 100k residents WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 624 units · 9.1 per 100k residents IN Ohio: 74,844 units · 635 per 100k residents OH Pennsylvania: 28,123 units · 217 per 100k residents PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 10,620 units · 171 per 100k residents MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 2,892 units · 33.2 per 100k residents VA Maryland: 4,366 units · 70.6 per 100k residents MD Connecticut: 4,990 units · 138 per 100k residents CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: 2,211 units · 75.2 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 3,969 units · 36.0 per 100k residents GA D.C.: 1,248 units · 184 per 100k residents DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
9.1635
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Ohio 635 /100k
2 Pennsylvania 217 /100k
3 Wisconsin 188 /100k
4 D.C. 184 /100k
5 Missouri 171 /100k
6 Connecticut 138 /100k
7 Kansas 75.2 /100k
8 Maryland 70.6 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Clotrimazole (matched by generic name) — the program that covers self-administered drugs. 13 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Clotrimazole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$6.43M
Claims incl. refills
276K
Beneficiaries
207.9K
Spend / beneficiary
$30.91
Spend / claim
$23.28
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Alevazol (this brand).

Top reported reactions

Macular Degeneration812
Nausea811
Pain777
Headache735
Dyspnoea706
Fatigue641
Diarrhoea598

Age at onset

Neonate46
Infant16
Child33
Adolescent23
Adult1,078
Elderly892

Reporter sex

11,492 reports
Male · 34%
Female · 65%
Unknown · 0%

Serious outcomes

Death925
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 1,034 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Capital Pharmaceutical, LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Capital Pharmaceutical, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 29978-0601-30 · Capital 29998-0001-30 · Kettering →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.